Table 3.
Adequacy and Adherence Percentages for Intervention and Control Groups Within the Low and High Depression Strata
| Low SCL Group (n = 149) | High SCL Group (n = 79) | χ2 (df = 1) | ||||
|---|---|---|---|---|---|---|
| Controls, % | Intervention, % | Controls, % | Intervention, % | Low | High | |
| 90-day adequacy | ||||||
| Low dosage | 46 | 67 | 39 | 72 | 6.10* | 8.23† |
| High dosage | 25 | 44 | 28 | 51 | 5.93* | 4.31* |
| Adherence | ||||||
| Baseline | 70 | 64 | 48 | 56 | 0.73 | 0.63 |
| 1 Month | 75 | 79 | 58 | 75 | 0.25 | 2.25 |
| 3 Months | 63 | 82 | 60 | 70 | 5.91* | 0.71 |
| 6 Months | 56 | 72 | 39 | 75 | 3.49 | 8.40† |
| Patients Taking SSRIs | ||||||
| Baseline | 61 | 61 | 45 | 49 | 0.001 | 0.01 |
| 1 Month | 55 | 73 | 45 | 59 | 4.47* | 1.04 |
| 3 Months | 43 | 67 | 38 | 51 | 7.34† | 1.01 |
| 6 Months | 46 | 56 | 30 | 54 | 1.13 | 3.68* |
P < .05;
P < .01.
SSRI indicates selective serotonin reuptake inhibitor.